Wysowski, D. K., and D. Barash. 1991. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's spontaneous reporting system. Archives of Internal Medicine 151:2003-2008.

Yonezawa, K., Y. Sugawara, H. Onuki, J. Abe, T. Miura, E. Musya, F. Ishizawa, and I. Yamaguchi. 1994. New trend of hipnotics given to outpatients and their response after changing triazolam tablet from 0.25 mg to 0.125 mg. Japanese Journal of Hospital Pharmacy 20(4):309-314.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement